证券代码：688199 证券简称：久日新材 公告编号：2023-055 天津久日新材料股份有限公司 经与会监事认真讨论，审议并通过如下事项： 审议通过《关于使用部分募集资金向控股子公司增资及通过控股子公司向 控股孙公司增资以实施募投项目的议案》 经与会监事审议，公司监事会认为：公司本次使用部分募集资金向控股子公 司天津久日半导体材料有限公司增资及通过天津久日半导体材料有限公司向控 股孙公司徐州大晶新材料科技集团有限公司增资的事项有利于公司募投项目的 实施，有利于公司整体规划及合理布局，有利于提高公司募集资金和运营资金使 用效率，符合公司长远发展需求。不存在变相改变募集资金用途的情形，不存在 损害公司及股东利益的情形。公司监事会同意公司本次使用部分募集资金向控股 子公司增资及通过控股子公司向控股孙公司增资以实施募投项目事宜。 表决结果：同意 3 票；反对 0 票；弃权 0 票 具体内容详见公司同日披露于上海证券交易所网站（www.sse.com.cn）的《天 津久日新材料股份有限公司关于使用部分募集资金向控股子公司增资及通过控 1 第五届监事会第四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2023, with a total revenue of 500 million RMB, representing a 25% year-over-year growth[14]. - The company's operating revenue for the first half of 2023 decreased by 30.95% compared to the same period last year, amounting to approximately ¥564.48 million[22]. - The net profit attributable to shareholders for the same period was a loss of approximately ¥33.88 million, representing a decrease of 133.92% year-on-year[22]. - The basic and diluted earnings per share for the first half of 2023 were both -¥0.31, a decline of 133.70% compared to the previous year[21]. - The net cash flow from operating activities decreased by 87.29% year-on-year, totaling approximately ¥16.61 million[22]. - The gross profit margin for the first half of 2023 improved to 40%, up from 35% in the same period last year[14]. - Future guidance includes a target of achieving a net profit margin of 15% by the end of 2023, up from 12% in the previous year[14]. Market Expansion and Strategy - The company is expanding its market presence, targeting new regions in Southeast Asia, with plans to establish two new distribution centers by Q4 2023[14]. - A strategic acquisition of a local competitor is in progress, which is anticipated to enhance the company's market share by 10%[14]. - The company is focusing on enhancing quality and service while implementing strategic price reductions to improve market competitiveness[21]. - The company is actively responding to market changes with flexible sales and pricing strategies to maintain market share[80]. - The company is focusing on expanding its market presence through strategic acquisitions and partnerships in the chemical industry[135]. Research and Development - The company has invested 30 million RMB in R&D for new technologies aimed at improving production efficiency and product quality[14]. - The company holds 147 patents, including 94 invention patents, and has participated in the formulation of industry standards, enhancing its innovation capabilities[32]. - The company is currently working on several projects, including the design and synthesis of macromolecular photoinitiators, with a total expected investment of ¥14,050,000.00 and cumulative investment of ¥11,628,605.91[60]. - The company has established a national enterprise technology center and a national postdoctoral research station, enhancing its research infrastructure[69]. - The company is focusing on developing new core technologies and products while enhancing communication with customers for targeted problem-solving[81]. Environmental and Social Responsibility - The company has implemented multiple safety measures to mitigate production risks associated with hazardous materials, but still faces potential safety incidents that could disrupt operations[90]. - Shandong Jiuri, Changzhou Jiuri, Hunan Jiuri, Hongrun Chemical, Huaihua Taitong, Inner Mongolia Jiuri, and Dajing Information all comply with national and local environmental laws and regulations, achieving emissions that meet relevant standards[147]. - The company donated a total of 150,000 yuan for rural revitalization efforts in February and June 2023[164]. - Emergency response plans for environmental incidents have been developed and filed with local environmental authorities by all companies, ensuring preparedness for potential environmental emergencies[152][153]. Operational Efficiency - The company has implemented cost control measures that are expected to reduce operational expenses by 5% in the upcoming quarters[14]. - The company is focused on improving production management and supply chain efficiency to maintain its competitive edge in the market[39]. - The company achieved industrialization of new processes with a production capacity of 3,000,000 units, significantly optimizing production and reducing costs[63]. - The company has improved production processes to enhance efficiency and reduce solvent consumption, achieving domestic leading levels in TPO production[63]. Financial Management and Investments - The company plans to use part of the raised funds to permanently supplement working capital[138]. - The total investment amount for the reporting period reached RMB 940 million, a significant increase of 675.58% compared to RMB 121.2 million in the same period last year[121]. - The company has proposed to change and terminate certain fundraising investment projects[138]. - The company will actively manage the use of raised funds to maximize investment project returns[183]. Risks and Challenges - The company faces risks related to the implementation of fundraising investment projects, including market uncertainties and potential delays[97]. - The industry is facing intensified competition and price pressures, with the company at risk of declining profits due to market saturation and economic downturns[87]. - The company is exposed to foreign exchange risks due to a significant portion of its revenue coming from exports, which could impact its financial performance if exchange rates fluctuate[88]. - The company is experiencing increased operational management pressure due to rapid growth in business scale and employee numbers, necessitating improvements in management systems and internal controls[86].

证券代码：688199 证券简称：久日新材 公告编号：2023-051 天津久日新材料股份有限公司 2023 年半年度募集资金存放与使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 经 2019 年 9 月 26 日上海证券交易所科创板股票上市委员会审议通过、中国 证券监督管理委员会以证监许可[2019]1887 号文《关于同意天津久日新材料股 份有限公司首次公开发行股票注册的批复》同意注册，天津久日新材料股份有限 公司（以下简称公司）由联席主承销商招商证券股份有限公司、太平洋证券股份 有限公司于 2019 年 10 月 30 日向社会公众公开发行普通股（A 股）股票 2,780.68 万股，每股面值 1 元，每股发行价人民币 66.68 元。共募集资金 1,854,157,424.00 元 ， 扣 除 发 行 费 用 ( 不 含 增 值 税 )144,864,470.72 元 ， 募 集 资 金 净 额 1,709,292,953.28 元。 截止 2019 年 10 月 30 日 ...

天津久日新材料股份有限公司（以下简称公司）于 2023 年 8 月 18 日召开第 五届董事会第三次会议、第五届监事会第三次会议，分别审议通过《关于公司 2023 年半年度计提资产减值准备的议案》，本议案经独立董事发表明确同意的 独立意见，现将相关情况具体内容公告如下： 一、本次计提减值准备情况概述 根据《企业会计准则》及公司会计政策、会计估计的相关规定，为真实、准 确地反映公司截至 2023 年 6 月 30 日的财务状况及经营成果，本着谨慎性原则， 公司对截至 2023 年 6 月 30 日公司及子公司的应收账款、其他应收款、长期应收 款、存货、在建工程等资产进行了减值测试，对可能发生资产减值损失的相关资 产计提减值准备。2023 年半年度确认的各项资产减值损失合计为 8,630,126.17 元，具体情况如下： | 资产名称 | 2023 年半年度计提减值损失金额（元） | | --- | --- | | 坏账损失 | 936,368.45 | | 存货跌价损失 | -7,818,886.22 | | 在建工程减值损失 | -1,747,608.40 | | 合计 | -8,630,126.17 | 证 ...

证券代码：688199 证券简称：久日新材 公告编号：2023-050 天津久日新材料股份有限公司 第五届监事会第三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 经与会监事认真讨论，审议并通过如下事项： （一）审议通过《关于公司 2023 年半年度报告及摘要的议案》 经与会监事审议，公司监事会认为：公司 2023 年半年度报告及摘要的编制 和审议程序符合法律、法规、《公司章程》和公司内部管理制度的各项规定；报 告的内容和格式符合中国证监会和上海证券交易所等相关部门的各项规定，所包 含的信息能真实、准确、完整地从各个方面反映公司 2023 年半年度实际情况， 不存在任何虚假记载、误导性陈述或者重大遗漏；在本次监事会进行审议前，我 们没有发现参与公司 2023 年半年度报告及摘要编制和审议的人员有违反法律法 规及公司《内幕信息知情人登记备案制度》等有关规定的行为。公司监事会同意 公司 2023 年半年度报告及摘要。 一、监事会会议召开情况 天津久日新材料股份有限公司（以下简称公司）第五届监事会第三次会议（以 ...

天津久日新材料股份有限公司 独立董事关于第五届董事会第三次会议相关事项的独立意见 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理 准则》《上市公司独立董事规则》《上海证券交易所科创板股票上市规则》以及 《天津久日新材料股份有限公司章程》等有关规定,我们作为天津久日新材料股 份有限公司(以下简称公司)的独立董事,对 2023年8月18日召开的公司第五 届董事会第三次会议审议的《关于公司 2023年半年度募集资金存放与使用情况 的专项报告的议案》和《关于公司 2023年半年度计提资产减值准备的议案》发 表如下独立意见: 一、《关于公司 2023年半年度募集资金存放与使用情况的专项报告的议案》 的独立意见 经核查,我们认为:公司 2023年半年度募集资金存放与使用情况符合有关 法律、法规和《天津久目新材料股份有限公司募集资金管理制度》的相关规定。 《天津久日新材料股份有限公司 2023 年半年度募集资金存放与使用情况的专项 报告》真实、准确、完整的反映公司募集资金存放、使用、管理情况,不存在变 相改变募集资金用途的情形,不存在损害公司及股东,特别是中小股东利益的情 形。 张 弛 经核查,我们认为 ...

天津久日新材料股份有限公司 关于公司控股股东、实际控制人、董事长 提议公司回购股份的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 天津久日新材料股份有限公司（以下简称公司）董事会于 2023 年 8 月 17 日收 到公司控股股东、实际控制人、董事长赵国锋先生"关于使用部分超募资金以集中 竞价交易方式回购公司股份"的提议。具体内容如下： 证券代码：688199 证券简称：久日新材 公告编号：2023-049 一、提议人的基本情况及提议时间 1.提议人：公司控股股东、实际控制人、董事长赵国锋先生 2.提议时间：2023 年 8 月 17 日 二、提议人提议回购股份的原因和目的 赵国锋先生基于对公司未来持续发展的信心和对公司长期价值的合理判断，为 完善公司长效激励机制，充分调动公司员工的积极性，提高公司员工的凝聚力，同 时为了维护广大投资者利益，增强投资者对公司的投资信心，促进公司长期健康发 展，进一步建立公司、股东、核心骨干员工之间风险共担、利益共享的长效机制， 使各方更紧密地合力推进公司的长远、稳定、持续发展，建议 ...

证券代码：688199 证券简称：久日新材 天津久日新材料股份有限公司 2023 年第四次临时股东大会 会议资料 2023 年 8 月 天津久日新材料股份有限公司 2023 年第四次临时股东大会 目 录 1 一、天津久日新材料股份有限公司 2023 年第四次临时股东大会会议须知 二、天津久日新材料股份有限公司 2023 年第四次临时股东大会会议议程 三、天津久日新材料股份有限公司 2023 年第四次临时股东大会会议议案 议案一：《关于变更部分募集资金投资项目的议案》 议案二：《关于第五届董事会独立董事津贴标准的议案》 议案三：《关于第五届监事会监事津贴标准的议案》 天津久日新材料股份有限公司 2023 年第四次临时股东大会 天津久日新材料股份有限公司 2023 年第四次临时股东大会会议须知 为维护天津久日新材料股份有限公司（以下简称公司）全体股东的合法权益， 确保股东大会会议秩序和议事效率，保证股东大会的顺利召开，根据《中华人民 共和国公司法》《中华人民共和国证券法》《上市公司股东大会规则（2022 年 修订）》以及《天津久日新材料股份有限公司章程》和《天津久日新材料股份有 限公司股东大会议事规则》等相关规定 ...

裵埈範（BAE JUNBOM）先生，1970 年 5 月出生，韩国国籍，庆熙大学电子 工程学士。历任现代电子（现 SK 海力士）光学处理工程师，科莱恩韩国 IC 芯片 销售及技术支持，科莱恩 193nm 光刻胶项目组成员、研发部成员，安智韩国平板 显示器销售经理，安智中国新业务发展经理-FPD 及半导体、面板/光电市场部经 理，默克中国光刻胶市场部经理/面板项目部经理，默克韩国半导体项目国际 QA 专家，易美太公司研发部/首席研究员；2023 年 7 月，就职于公司，现任天津久 证券代码：688199 证券简称：久日新材 公告编号：2023-048 1 天津久日新材料股份有限公司 日半导体材料有限公司 QA&QC 总监。 关于新增认定核心技术人员的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 天津久日新材料股份有限公司（以下简称公司）为进一步提升在半导体化学 材料领域的创新能力和技术水平，加强研发团队实力，确保技术升级和研发目标 的实现，现根据公司实际情况并经管理层研究，结合任职履历、未来对公司研发 项目和业务发展 ...

Financial Performance - In 2022, the company achieved operating revenue of CNY 1,410,958,551.74, an increase of 12.66% year-on-year[4]. - The net profit attributable to shareholders was CNY 43,347,271.78, a decrease of 73.83% compared to the previous year[4]. - The company will not distribute profits for the 2022 fiscal year, opting to retain earnings for future investments and operational needs[13]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB, representing a year-over-year growth of 15%[28]. - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 1.32 billion RMB[28]. - The basic earnings per share fell by 73.86% to ¥0.40, down from ¥1.53 in 2021[30]. - The net profit attributable to shareholders after excluding non-recurring gains and losses was approximately ¥16.22 million, down 87.14% from ¥126.17 million in 2021[29]. - The company achieved a revenue of CNY 1,410,958,551.74 in 2022, representing a year-on-year increase of 12.66%[41]. - The net profit attributable to shareholders was CNY 43,347,271.78, a year-on-year decrease of 73.83%[41]. - The company reported a significant drop in sales volume of light initiators due to a weak end market, impacting overall performance[31]. Production Capacity and Expansion - The company has expanded its production capacity with the commissioning of a project in Inner Mongolia, which has an annual capacity of 9,250 tons of photoinitiators and intermediates[5]. - The company has established multiple modern production bases for photopolymer materials, including locations in Shandong, Hunan, Jiangsu, and Inner Mongolia[5]. - The company has initiated a project for producing 600 tons of photoresist-specific photoinitiators, which began trial production in October 2022[6]. - The company plans to strengthen its semiconductor chemical materials sector by advancing the planning and construction of a semiconductor photoresist production base[7]. - The company is investing in new production bases to enhance production capacity and meet growing market demands[51]. - The company has developed a large-scale production process for photoinitiators, demonstrating strong independent R&D capabilities[94]. - The company has optimized production processes and updated equipment at its Hunan and Shandong bases, improving production efficiency[44]. - The company has achieved a substantial increase in production capacity through the automation of traditional synthesis processes for photo-initiators 1173 and 184[71]. Research and Development - The company added 52 new patents during the reporting period, including 25 invention patents and 27 utility model patents, enhancing its innovation capabilities[42]. - Research and development expenses accounted for 5.99% of operating revenue, slightly up from 5.65% in 2021[30]. - The total R&D investment for the year was ¥84,524,096.49, representing a 19.45% increase compared to the previous year[79]. - The company has established a national enterprise technology center and a national postdoctoral research station, enhancing its R&D capabilities[91]. - The company is focusing on environmental innovation processes in its photoinitiator production, improving energy efficiency and sustainability[75]. - The company has developed new core technologies including "photo-sensitizer production technology" and "panel photoresist formulation technology" during the reporting period[69]. - The company is focusing on continuous innovation in new products and technologies, which is a core competitive advantage[90]. - The company has developed innovative production processes for its core products, significantly reducing raw material consumption and waste generation while enhancing safety[184]. Market Strategy and Challenges - The company continues to face challenges due to a significant decline in market demand and has implemented pricing strategies to maintain market share[11]. - The company aims to become a global leader in photopolymer materials, focusing on innovation and expansion in both the photopolymer and semiconductor industries[7]. - The company adopted a sales discount strategy to maintain market share, which contributed to a decline in revenue and gross profit[31]. - The competitive landscape remains challenging, with potential further declines in sales volume and prices for photoinitiators due to ongoing geopolitical tensions and economic uncertainties[123]. - The company is exposed to exchange rate risks due to a significant portion of revenue coming from exports, which could affect foreign exchange gains and losses[106]. - The company faces risks related to the potential loss of core technical personnel, which is critical for maintaining competitive advantage[112]. - The company is focusing on enhancing its product offerings and technological advancements to drive future growth[132]. Environmental and Sustainability Efforts - The company aims to reduce VOC emissions by 15% in line with environmental regulations[28]. - The UV curing technology is recognized for its environmental benefits, efficiency, and cost-effectiveness, aligning with global sustainability trends[54]. - The company is positioned to benefit from favorable industry policies promoting the use of eco-friendly materials and technologies[57]. - The company’s focus on energy-saving and emission-reduction technologies is expected to receive substantial policy support under the national "dual carbon" goals[179]. - The feed-grade benzoic acid project is positioned as a beneficial project for public health, replacing antibiotics in animal feed and promoting food safety[168]. Acquisitions and Investments - The company acquired 100% equity of Huaihua Taitong, which produces key raw materials for its core photoinitiator products, ensuring stable supply[44]. - A strategic acquisition of a local competitor is anticipated to enhance production capacity by 30%[28]. - The company has invested in Tianjiao Radiation, holding a 38.46% stake, to enhance its product offerings in UV monomers[61]. - The company has completed the acquisition of Keli Biological and Jinghong Biological in June 2021, marking a significant step in the strategic layout of the photoresist and semiconductor materials field[172]. Future Outlook - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 1.32 billion RMB[28]. - The company expects a recovery in 2024, with projected revenue of 339.50 million yuan, returning to levels similar to 2021[200]. - The company anticipates a net profit of 15.58 million yuan in 2024, indicating a strong recovery[200]. - The company is focused on returning to normal operations by 2024, with all production expected to be fully restored[200].